Multiple Sclerosis Conference had scores of Vitamin D presentations

Created September 2016

European Committee for the Treatment and Research in Multiple Sclerosis

Here are just some of the titles. Files are available at the above link for 2016, 2015, etc

* Multiple Sclerosis Treatment and Research -Vitamin D presentations at European Congress Oct 2015 * Previous year of the conference * Interview and transcript: Vitamin D protocol for Autoimmune diseases – Dr. Coimbra 2016 * He has been able to virtually cure thousands of MS patients, but does not do RCT, so is ignored by most others * Multiple Sclerosis **category listing has items along with related searches** * Overview MS and vitamin D

Abstracts

  • Influence of 25(OH)D levels and genetic variants on disease severity in MS; Till Andlauer (Sep 16, 2016; 146027)

  • Low levels of vitamin D in neuromyelitis optica and neuromyelitis optica spectrum: association with quality of life; Yesim Beckmann (Sep 16, 2016; 146071)

  • Vitamin D metabolic pathway alterations and risk of multiple sclerosis in patients with clinically isolated...; Antonio Farina (Sep 16, 2016; 146832)

  • Vitamin D genetic risk score is strongly associated with vitamin D levels and relapse rate in pediatric MS patients; Jennifer Graves (Sep 16, 2016; 146672)

  • Selective and transient effect of vitamin D 3 supplementation on antibody responses against...; Egil Røsjø (Sep 16, 2016; 146826)

  • Baseline vitamin D levels and multiple sclerosis activity in relapsing-remitting patients treated with fingolimod; Laura Ferrè (Sep 16, 2016; 146827)

  • Severe vitamin D deficiency and smoking increases the risk of multiple sclerosis and disability accumulation in...; Maria Isabel Zuluaga (Sep 16, 2016; 147079)

  • High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple...; Raymond Hupperts (Sep 16, 2016; 147013)

  • Historical but not current vitamin D & sun parameters are associated with a more favourable multiple sclerosis...; Bruce Taylor (Sep 15, 2016; 146153)

  • Shift work at young age and risk of multiple sclerosis; Stefan Gustavsen (Sep 15, 2016; 146147)

  • Changes in sun & vitamin D behaviours and their relationships with vitamin D during five years of follow-up in...; Bruce Taylor (Sep 15, 2016; 146154)

  • Relationship between Vitamin D levels and cognitive impairment, depression and fatigue in relapsing remitting...; Berenice Silva (Sep 15, 2016; 146422)

  • Mendelian randomization provides evidence for a causal effect of low vitamin D on multiple sclerosis risk in two...; Maria Bäärnhielm (Sep 15, 2016; 146292)

  • High dose vitamin D 3 supplementation does not ameliorate depressive symptoms in relapsing remitting...; Linda Rolf (Sep 15, 2016; 146601)

  • Association of serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple...; Halil Atilla Idrisoglu (Sep 15, 2016; 146513)

  • Gene-environment interaction study in multiple sclerosis using a “candidate-interactome” approach; Rosella Mechelli (Sep 15, 2016; 146293)

  • Immune regulatory effects of high dose vitamin D 3 supplementation in a randomized controlled trial in...; Anne-Hilde Muris (Sep 15, 2016; 146467)

  • Cholecalciferol supplementation in relapsing multiple sclerosis patients treated with subcutaneous interferon...; William Camu (Sep 15, 2016; 146590)

  • Environmental factors associated with progression of MS; Alberto Ascherio (Sep 15, 2016; 147006)

  • Vitamin D levels and incidence of postpartum relapses; Krupa Pandey (Sep 14, 2016; 145472)

  • Increased contact with clinical trial participants may improve confirmed multiple sclerosis relapse detection; Ellen Mowry (Sep 14, 2016; 145497)

Eposters

  • Influence of 25(OH)D levels and genetic variants on disease severity in MS; Till Andlauer (Sep 16, 2016; 146027)

  • Vitamin D metabolic pathway alterations and risk of multiple sclerosis in patients with clinically isolated...; Antonio Farina (Sep 16, 2016; 146832)

  • Selective and transient effect of vitamin D 3 supplementation on antibody responses against...; Egil Røsjø (Sep 16, 2016; 146826)

  • Baseline vitamin D levels and multiple sclerosis activity in relapsing-remitting patients treated with fingolimod; Laura Ferrè (Sep 16, 2016; 146827)

  • Shift work at young age and risk of multiple sclerosis; Stefan Gustavsen (Sep 15, 2016; 146147)

  • Multiple sclerosis and Hashimoto's thyroiditis: differences and similarities in the immune regulation; Simona Perga (Sep 15, 2016; 146276)

  • Mendelian randomization provides evidence for a causal effect of low vitamin D on multiple sclerosis risk in two...; Maria Bäärnhielm (Sep 15, 2016; 146292)

  • Immune regulatory effects of high dose vitamin D 3 supplementation in a randomized controlled trial in...; Anne-Hilde Muris (Sep 15, 2016; 146467)

  • Prevalence and predictors of lymphopenia in multiple sclerosis (MS) patients treated with fingolimod (FG) or...; Moogeh Baharnoori (Sep 15, 2016; 146564)

  • Cholecalciferol supplementation in relapsing multiple sclerosis patients treated with subcutaneous interferon...; William Camu (Sep 15, 2016; 146590)

  • High dose vitamin D 3 supplementation does not ameliorate depressive symptoms in relapsing remitting...; Linda Rolf (Sep 15, 2016; 146601)

  • Multiple sclerosis and diet: systematic review, internet-based survey and pilot-testing of an evidence based...; Christoph Heesen (Sep 15, 2016; 146621)

  • Vitamin D levels and incidence of postpartum relapses; Krupa Pandey (Sep 14, 2016; 145472)

  • Increased contact with clinical trial participants may improve confirmed multiple sclerosis relapse detection; Ellen Mowry (Sep 14, 2016; 145497)

  • 1,25-dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving...; Agnes Elisabeth Nystad (Sep 14, 2016; 145515)

  • Vitamin D levels and severity in multiple sclerosis patients from the North of Portugal; Andreia Bettencourt (Sep 14, 2016; 145528)

Webcasts

  • Severe vitamin D deficiency and smoking increases the risk of multiple sclerosis and disability accumulation in...; Maria Isabel Zuluaga (Sep 16, 2016; 147079)

  • High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple...; Raymond Hupperts (Sep 16, 2016; 147013)

  • Serum levels of 25-hydroxyvitamin D and risk of multiple sclerosis among women in the Finnish Maternity Cohort; Alberto Ascherio (Sep 16, 2016; 147045)

  • Correlates of cognitive impairment in multiple sclerosis: do environmental and lifestyle risk factors for the...; Isabella Righini (Sep 16, 2016; 147069)

  • Environmental factors associated with progression of MS; Alberto Ascherio (Sep 15, 2016; 147006)

  • The role of Vitamin D in utero; Lucy Ruscoe (Sep 14, 2016; 147287)

Tags: Multiple Sclerosis